Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen Sells 10,300 Shares of Stock

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 10,300 shares of Strata Critical Medical stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $5.79, for a total value of $59,637.00. Following the transaction, the chief accounting officer owned 191,838 shares of the company’s stock, valued at $1,110,742.02. This represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Amir Cohen also recently made the following trade(s):

• On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.91, for a total value of $239,798.25.

Strata Critical Medical Price Performance

Shares of Strata Critical Medical stock opened at $6.14 on Wednesday. Strata Critical Medical has a 1 year low of $3.40 and a 1 year high of $6.27. The firm has a market cap of $531.29 million, a P/E ratio of -76.75 and a beta of 2.15. The stock’s 50 day moving average is $4.85.

Strata Critical Medical (NASDAQ:SRTA) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.07. Strata Critical Medical had a negative return on equity of 4.06% and a net margin of 20.56%.The firm had revenue of $67.38 million during the quarter. As a group, equities research analysts expect that Strata Critical Medical will post -0.14 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. B. Riley Financial assumed coverage on Strata Critical Medical in a research report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective for the company. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Finally, Craig Hallum began coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.

Institutional Trading of Strata Critical Medical

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of America Corp DE grew its stake in Strata Critical Medical by 16.2% in the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after acquiring an additional 25,379 shares during the period. Quantinno Capital Management LP grew its stake in Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after acquiring an additional 71,155 shares during the period. Dimensional Fund Advisors LP grew its stake in Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after acquiring an additional 172,154 shares during the period. Principal Financial Group Inc. purchased a new stake in Strata Critical Medical in the 1st quarter worth approximately $537,000. Finally, Granite Investment Partners LLC grew its stake in Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after acquiring an additional 7,911 shares during the period. 47.36% of the stock is owned by hedge funds and other institutional investors.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.